Big Data in Laboratory Medicine-FAIR Quality for AI?

被引:15
|
作者
Blatter, Tobias Ueli [1 ]
Witte, Harald [1 ]
Nakas, Christos Theodoros [1 ,2 ]
Leichtle, Alexander Benedikt [1 ,3 ]
机构
[1] Univ Hosp Bern, Dept Clin Chem, Inselspital, CH-3010 Bern, Switzerland
[2] Univ Thessaly, Lab Biometry, Volos 38446, Greece
[3] Univ Bern, Ctr Artificial Intelligence Med CAIM, CH-3010 Bern, Switzerland
关键词
digitalization; clinical chemistry; artificial intelligence; interoperability; FAIRification; OMICS;
D O I
10.3390/diagnostics12081923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laboratory medicine is a digital science. Every large hospital produces a wealth of data each day-from simple numerical results from, e.g., sodium measurements to highly complex output of "-omics" analyses, as well as quality control results and metadata. Processing, connecting, storing, and ordering extensive parts of these individual data requires Big Data techniques. Whereas novel technologies such as artificial intelligence and machine learning have exciting application for the augmentation of laboratory medicine, the Big Data concept remains fundamental for any sophisticated data analysis in large databases. To make laboratory medicine data optimally usable for clinical and research purposes, they need to be FAIR: findable, accessible, interoperable, and reusable. This can be achieved, for example, by automated recording, connection of devices, efficient ETL (Extract, Transform, Load) processes, careful data governance, and modern data security solutions. Enriched with clinical data, laboratory medicine data allow a gain in pathophysiological insights, can improve patient care, or can be used to develop reference intervals for diagnostic purposes. Nevertheless, Big Data in laboratory medicine do not come without challenges: the growing number of analyses and data derived from them is a demanding task to be taken care of. Laboratory medicine experts are and will be needed to drive this development, take an active role in the ongoing digitalization, and provide guidance for their clinical colleagues engaging with the laboratory data in research.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Transforming cancer drug discovery with Big Data and AI
    Workman, Paul
    Antolin, Albert A.
    Al-Lazikani, Bissan
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (11) : 1089 - 1095
  • [22] Potential abuses of dominance by big tech through their use of Big Data and AI
    Hutchinson, Christophe Samuel
    JOURNAL OF ANTITRUST ENFORCEMENT, 2022, 10 (03) : 443 - 468
  • [23] Big Data/AI in Neurocritical Care: Maybe/Summary
    Suarez, Jose, I
    NEUROCRITICAL CARE, 2022, 37 (SUPPL 2) : 166 - 169
  • [24] Trustworthy AI in the Age of Pervasive Computing and Big Data
    Kumar, Abhishek
    Braud, Tristan
    Tarkoma, Sasu
    Hui, Pan
    2020 IEEE INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATIONS WORKSHOPS (PERCOM WORKSHOPS), 2020,
  • [25] Dealing with the big data challenges in AI for thermoelectric materials
    Jia, Xue
    Aziz, Alex
    Hashimoto, Yusuke
    Li, Hao
    SCIENCE CHINA-MATERIALS, 2024, 67 (04) : 1173 - 1182
  • [26] AI Empowered Big Data Analytics for Industrial Applications
    Kumar, V. D. Ambeth
    Varadarajan, Vijayakumar
    Gupta, Mukesh Kumar
    Rodrigues, Joel J. P. C.
    Janu, Neha
    JOURNAL OF UNIVERSAL COMPUTER SCIENCE, 2022, 28 (09) : 877 - 881
  • [27] Drug repositioning for cancer in the era of AI, big omics, and real-world data
    Wieder, Robert
    Adam, Nabil
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 175
  • [28] AI for Social Good: AI and Big Data Approaches for Environmental Decision-Making
    Li, Victor O. K.
    Lam, Jacqueline C. K.
    Cui, Jiahuan
    ENVIRONMENTAL SCIENCE & POLICY, 2021, 125 : 241 - 246
  • [30] NOMAD: The FAIR concept for big data-driven materials science
    Draxl, Claudia
    Scheffler, Matthias
    MRS BULLETIN, 2018, 43 (09) : 676 - 682